Laboratorios Farmaceuticos Rovi S.A.
ROVI | MC
Overview
Corporate Details
- ISIN(s):
- ES0157261019
- LEI:
- 95980020140005936480
- Country:
- Spain
- Address:
- JULIAN CAMARILLO 35, 28037 Madrid
- Website:
- https://www.rovi.es/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ROVI is a fully integrated Spanish specialty pharmaceutical company engaged in the research, development, in-licensing, manufacturing and marketing of small molecule and specialty biologic drugs. To date, thanks to our 22 alliances with international partners, our principal product, Bemiparin, is now present in more than 55 countries. With our Enoxaparin Biosimilar, we hope to increase our presence in Europe, the United States and emerging countries.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Laboratorios Farmaceuticos Rovi S.A..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-18 00:00 |
Post-Annual General Meeting Information
La Sociedad informa sobre los acuerdos adoptados por su Junta General Ordinaria…
|
Spanish | 152.8 KB | |
| 2025-05-08 07:56 |
Pre-Annual General Meeting Information
La Sociedad informa sobre el acuerdo de convocatoria de su Junta General Ordina…
|
Spanish | 488.2 KB | |
| 2025-05-08 07:54 |
Regulatory News Service
ROVI informa sobre la concesión de una subvención en su favor para el desarroll…
|
Spanish | 171.1 KB | |
| 2025-05-08 07:39 |
Investor Presentation
La Compañía hace pública la presentación relativa a los resultados financieros …
|
Spanish | 957.7 KB | |
| 2025-05-08 07:35 |
Earnings Release
La Compañía hace público el comunicado de prensa relativo a los resultados fina…
|
Spanish | 631.0 KB | |
| 2025-05-08 00:00 |
Pre-Annual General Meeting Information
La Sociedad informa sobre el acuerdo de convocatoria de su Junta General Ordina…
|
Spanish | 488.2 KB | |
| 2025-04-04 10:27 |
Transaction in Own Shares
Operaciones sobre acciones propias efectuadas en el primer trimestre de 2025 en…
|
Portuguese | 219.9 KB | |
| 2025-03-25 10:03 |
Investor Presentation
La Sociedad hace pública de nuevo la presentación en español relativa a la actu…
|
Spanish | 2.3 MB | |
| 2025-03-25 08:00 |
Investor Presentation
La Sociedad hace pública la presentación relativa a la actualización de su estr…
|
Spanish | 2.3 MB | |
| 2025-02-25 07:54 |
Report Publication Announcement
La Sociedad informa sobre los acuerdos adoptados por su Consejo de Administraci…
|
Spanish | 85.6 KB | |
| 2025-02-25 07:49 |
Investor Presentation
La Sociedad hace pública la presentación de los resultados financieros del ejer…
|
Spanish | 1.4 MB | |
| 2025-02-25 07:47 |
Earnings Release
La Sociedad hace público el comunicado de prensa relativo a los resultados fina…
|
Spanish | 672.9 KB | |
| 2025-02-25 07:15 |
Remuneration Information
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del …
|
Spanish | 236.7 KB | |
| 2025-02-25 07:10 |
Governance Information
La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2024
|
Spanish | 3.5 MB | |
| 2025-02-25 00:00 |
Annual / Quarterly Financial Statement
|
English | 615.4 KB |
Automate Your Workflow. Get a real-time feed of all Laboratorios Farmaceuticos Rovi S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Laboratorios Farmaceuticos Rovi S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nippon Shinyaku Co.,Ltd. | Japan | 4516 | |
|
Noile-Immune Biotech Inc. | Japan | 4893 | |
|
Novartis AG | Switzerland | NOVN | |
|
Nur Ink Innovations Ltd. | Israel | NURI | |
|
Nxera Pharma Co., Ltd. | Japan | 4565 | |
|
ObsEva SA | Switzerland | OBSN | |
|
ODI Pharma AB | Sweden | ODI | |
|
Oncolys BioPharma Inc. | Japan | 4588 | |
|
OncoTherapy Science, Inc. | Japan | 4564 | |
|
OncoZenge AB | Sweden | ONCOZ |